Harford County, Md. GO Bond Rating Raised To 'AA+' From 'AA';Strong Management Practices Cited Jan 04

  • ID: 2038705
  • January 2004
  • Standard & Poors
1 of 3

NEW YORK (Standard & Poor's) Jan. 23, 2004Standard & Poor's Ratings Services has raised its rating on Harford County, Md.'s outstanding GO bonds to 'AA+' from 'AA' based on strong management practices that have contributed to historically strong financial performance, along with tax raising flexibility, a low debt profile, and ongoing growth and diversification in the economic base. The outlook is stable. At the same time, Standard & Poor's assigned its 'AA+' rating to the county's $27.93 million consolidated public improvement bonds, series 2004. The bonds are expected to sell on Jan. 27. The rating further reflects a growing and diversifying local economy, with employment in the federal government, research and development, and warehouse and distribution companies, and that also...

Companies mentioned in this report are:
- Harford Cnty

Action: New Rating

Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, insurance companies, utilities, sovereigns and structured finance programs. RatingsXpress Credit Research lets users determine the credit rating of holdings and identify key factors underlying an issuer's creditworthiness, distinguishes the different risk exposures for new and existing deals, and provides an understanding of how their analysts interpret key regulatory, political and environmental events and their economic impact.

Research type: News
This product is a is a brief one-page announcement of no more than 500 words with a quote from the analyst. It is media and investor focused with no accompanying commentary article.

Note: Product cover images may vary from those shown
2 of 3

- Harford Cnty

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown




Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer Inc.